Complete Genomics (NASDAQ: GNOM) and Veeva Systems (NYSE:VEEV) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Earnings & Valuation

This table compares Complete Genomics and Veeva Systems’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Complete Genomics N/A N/A N/A ($2.35) -1.34
Veeva Systems $544.04 million 14.29 $68.80 million $0.86 65.19

Veeva Systems has higher revenue and earnings than Complete Genomics. Complete Genomics is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings for Complete Genomics and Veeva Systems, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Complete Genomics 0 0 0 0 N/A
Veeva Systems 0 4 7 0 2.64

Veeva Systems has a consensus price target of $67.70, indicating a potential upside of 20.76%. Given Veeva Systems’ higher probable upside, analysts plainly believe Veeva Systems is more favorable than Complete Genomics.

Institutional & Insider Ownership

72.4% of Veeva Systems shares are owned by institutional investors. 19.2% of Veeva Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Complete Genomics and Veeva Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Complete Genomics N/A N/A N/A
Veeva Systems 19.97% 12.21% 9.01%

Summary

Veeva Systems beats Complete Genomics on 9 of the 9 factors compared between the two stocks.

About Complete Genomics

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

About Veeva Systems

Veeva Systems Inc. (Veeva) is a provider of cloud-based software solutions for the global life sciences industry. The Company offers solutions for a range of requirements within life sciences companies, including multichannel customer relationship management, regulated content and information management, master data management and customer data. The Company offers solutions to areas, including the Veeva CRM family of applications for multichannel customer relationship management to enable coordinated and personalized customer engagement through multiple touch points; Veeva Vault for regulated content management and information management solutions to enable the management of content-centric processes; the Veeva Network master data management solutions for the management of customer master and product master data, and Veeva’s data and data services offerings, including Veeva OpenData for customer reference data and Veeva KOL Data for data.

Receive News & Ratings for Complete Genomics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Complete Genomics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.